Topical drug bioavailability, bioequivalence, and penetration (New York, 2014). - ОГЛАВЛЕНИЕ / CONTENTS
Навигация

Архив выставки новых поступлений | Отечественные поступления | Иностранные поступления | Сиглы
ОбложкаTopical drug bioavailability, bioequivalence, and penetration / red. V.P.Shah. - 2nd ed. - New York: Springer Science+Business Media, 2014. - xiii, 402 p. : ill. - Bibliogr. at the end of the chapters. - Ind.: p.399-402. - ISBN 978-1-4939-1288-9
Шифр: (И/Р28-T75) 02

 

Место хранения: 02 | Отделение ГПНТБ СО РАН | Новосибирск

Оглавление / Contents
 
Part I. Percutaneous Absorption
1  Percutaneous Absorption ...................................... 3
   Michael S. Leo and Howard I. Maibach
2  Animal Modeis for Percutaneous Absorption ................... 21
   Eui Chang Jung and Howard I. Maibach
3  Mitigating Dermal Exposure to Agrochemicals ................. 41
   Robert P. Chilcott

Part II. In Vitro Drug Release
4  Importance of In Vitro Drug Release ......................... 61
   Vinod P. Shah and Roger L. Williams
5  Diffusion Cell Design ....................................... 79
   Jon R. Heylings
6  In Vitro Product Quality Tests and Product Performance
   Tests for Topical and Transdermal Drug Products ............. 81
   Avraham Yacobi, Clarence T. Ueda and Vinod P. Shah
7  Safety and Efficacy Testing of Topical Products; Practical
   Considerations .............................................. 91
   Rashmikant Mohile

Part III. Bioequivalence of Topical Drug Products
8  Challenges in Evaluating Bioequivalence of Topical
   Dermatological Drug Products ............................... 101
   Vinod P. Shah and Roger L. Williams
9  Methods for the Assessment of Bioequivalence of Topical
   Dosage Forms: Correlations, Optimization Strategies,
   and Innovative Approaches .................................. 113
   Isadore Kanfer
10 Application of Microdialysis in Assessing Cutaneous
   Bioavailability ............................................ 153
   Eva Benfeldt

Part IV. Bioequivalence: Targeted Drug Delivery
11 Follicular Drug Penetration ................................ 169
   Jürgen Lademann and Alexa Patzelt
12 Development of Pilosebaceous Unit-Targeted Drug Products ... 181
   Guang Wei Lu, Kevin S. Warner and Fangjing Wang
13 Deep Percutaneous Penetration into Muscles and Joints:
   Update ..................................................... 217
   Vladyslava Doktor, Christine M. Lee and Howard I. Maibach
14 Efficacy and Toxicity of Microneedle-Based Devices ......... 237
   Michael S. Leo, Hadar A. Lev-Tov, Faranak Kamangar,
   Howard I. Maibach and Raja K. Sivamani

Part V. Transdermal Drugs and Modelling
15 Mathematical Models for Topical and Transdermal Drug
   Products ................................................... 249
   Yuri G. Anissimov and Michael S. Roberts
16 Transdermal Patches: An Industrial Perspective
   on the Relevance of In Vitro Skin Permeation Studies
   and Approaches on Design of Manufacturing Processes ........ 299
   Björn Schurad and Marieke Gosau
17 Transdermal Drug Delivery Systems .......................... 319
   Vinod P. Shah and Roger L. Williams

Part VI. Clinical Studies and Bioequivalence
18 Dermal Estradiol and Testosterone Transfer in Man:
   Existence, Models, and Strategies for Prevention ........... 331
   Aaron Gandhi, K. L. Busse and Howard I. Maibach
19 Effects of Occlusion on Dermal Drug Delivery: Implications
   for Bioequivalence Measurement ............................. 351
   Nilab Osman and Howard I. Maibach
20 Challenges with Clinical Endpoints - Bioequivalence ........ 361
   Garrett Coman, Nicholas Blickenstaff and Howard
   I. Maibach
21 Clinical Considerations of Bioequivalence for Topical
   Dermatologie Drugs ......................................... 371
   Jessica Schweitzer and Howard I. Maibach

Part VII. Guidelines and Workshop Report
22 OECD Test Guideline 428 - A Method for In Vitro
   Percutaneous Absorption Measurement? ....................... 381
   John Jenner
23 Bioequivalence, Quality, and Novel Assessment Technologies
   for Topical Products: Current Challenges and Future
   Prospects .................................................. 389
   Vinod P. Shah, Avraham Yacobi and Majella E. Lane

Index ......................................................... 399


Архив выставки новых поступлений | Отечественные поступления | Иностранные поступления | Сиглы
 

[О библиотеке | Академгородок | Новости | Выставки | Ресурсы | Библиография | Партнеры | ИнфоЛоция | Поиск]
  © 1997–2024 Отделение ГПНТБ СО РАН  

Документ изменен: Wed Feb 27 14:28:56 2019. Размер: 7,619 bytes.
Посещение N 1035 c 23.08.2016